Evidence map›Paper›PMID 34903048›Full record

ArticlemBio2021

Human Cytomegalovirus UL138 Protein Inhibits the STING Pathway and Reduces Interferon Beta mRNA Accumulation during Lytic and Latent Infections.

Emily R Albright, Clayton K Mickelson, Robert F Kalejta

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Small bowel perforation due to cytomegalovirus infection in a patient with HIVBiomedica : revista del Instituto Nacional de Salud · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. A comprehensive method for quantifying human cytomegalovirus plaque assays.Frontiers in cellular and infection microbiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. [Mechanism and significance of cell senescence induced by viral infection].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. The Pentamer glycoprotein complex inhibits viral Immediate Early transcription during Human Cytomegalovirus infections.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Human cytomegalovirus and neonatal infection.Current research in microbial sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Emily R AlbrightInstitute for Molecular Virology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Clayton K MickelsonInstitute for Molecular Virology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Robert F KalejtaInstitute for Molecular Virology, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-7116-3355
University of Wisconsin–Madison · US

Funding

Transcriptional Control of Human Cytomegalovirus LatencyR01AI130089 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ROBERT F KALEJTA · 2018 to 2026
$3.2M
Evading innate immunity during human cytomegalovirus latencyR01AI139180 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KALEJTA, ROBERT F · 2018 to 2022
$1.8M
NIAID NIH HHS R01 AI130089NIAID NIH HHS R01 AI139180
6 · The paper itself

Abstract

The cGAS/STING/TBK1 (cyclic guanine monophosphate-AMP synthase/stimulator of interferon genes/Tank-binding kinase 1) innate immunity pathway is activated during human cytomegalovirus (HCMV) productive (lytic) replication in fully differentiated cells and during latency within incompletely differentiated myeloid cells. While multiple lytic-phase HCMV proteins neutralize steps along this pathway, none of them are expressed during latency. Here, we show that the latency-associated protein UL138 inhibits the cGAS/STING/TBK1 innate immunity pathway during transfections and infections, in fully differentiated cells and incompletely differentiated myeloid cells, and with loss of function and restoration of function approaches. UL138 inhibits the pathway downstream of STING but upstream of interferon regulatory factor 3 (IRF3) phosphorylation and NF-κB function and reduces the accumulation of interferon beta mRNA during both lytic and latent infections.

Indexed as

CytomegalovirusCytomegalovirus InfectionsInterferon-betaMembrane ProteinsVirus LatencyHost-Pathogen InteractionsHumansImmunity, InnateInterferon Regulatory Factor-3Latent InfectionNF-kappa BProtein Serine-Threonine KinasesRNA, MessengerSignal TransductionSTING ProteinViral ProteinsInterferon-betaInterferon Regulatory Factor-3IRF3 protein, humanMembrane ProteinsNF-kappa BProtein Serine-Threonine KinasesRNA, MessengerSTING1 protein, humanSTING ProteinTBK1 protein, humanUL138 protein, human cytomegalovirusViral ProteinscGASHCMVherpesinnate immunitylatencylatentPAMPpersistentproductivePRRTBK1

Identifiers

PMID34903048
PMCPMC8669494
OpenAlexW4200083460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.